Skip to content

The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians

The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02620709
Acronym
KaHOLO
Enrollment
275
Registered
2015-12-03
Start date
2016-01-31
Completion date
2021-01-31
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Native Hawaiians, Community-based participatory research, Health disparities, Minority populations, Chronic disease

Brief summary

This project is a community-engaged, randomized control trial of hula, the indigenous dance form of Native Hawaiians (NH), among 250 NHs with hypertension living in Hawaii and Washington State. Investigators will compare the effects of a 6-month intervention, called the KaHOLO Program, delivered by trained peer educators to a wait-list control condition on blood pressure and 10-year cardiovascular risk. The intervention will be comprised of hula plus hypertension self-care education program. Investigators will also examine the mediating effects of health behaviors, self-regulation, psychosocial, and socio-cultural factors on blood pressure reduction. The ultimate goal is to develop and test a culturally-appropriate, acceptable, and effective intervention that can be delivered and sustained in community settings.

Detailed description

Native Hawaiians (NH) have higher rates of chronic diseases, such as cardiovascular disease (CVD), diabetes, and cancer. Hypertension (HTN), an important modifiable risk factor for CVD, is 70% higher in Native Hawaiians (NH) than in Whites. In fact, NH are 3-4 times more likely to develop CVD conditions, such as stroke and coronary heart disease, and at a younger age. In addition to prescribed medication, improvements in HTN can be achieved through increased physical activity (PA) and self-management education (e.g. stress management, reduces sodium intake, weight-loss, and smoking cessation). Yet, many commonly prescribed PA, such as jogging and use of treadmills, are difficult for NH to initiate and maintain because of socioeconomic barriers and lack of alignment with NH preferred modes of living and cultural values (i.e. familial interdependence, group-based PA, cultural PA). This research study uses hula, the traditional dance form of NH and hallmark of NH culture, as the PA basis for a culturally relevant and sustainable CVD prevention program targeting HTN management. Hula training is popular, not only Hawai'i, but across the U.S. through the 784 hālau hula (hula schools) found in most States. Using a community-based participatory research (CBPR) framework, a hula-based CVD health intervention was strongly endorsed by Kumu hula (hula experts and guardians of hula traditions), NH individuals, and communities. Further, hula was determined to yield metabolic equivalent of energy expenditure as a moderate and vigorous intensity PA. Data from a pilot CBPR randomized control trial (RCT) study found that 60 minutes of hula training twice a week for 12 weeks reduced systolic blood pressure (BP) by 7.5 mmHg (SD=16.5) more than the control group, but the long-term effects were mixed and the study did not assess CVD risk. Interestingly, the pilot intervention also improved social functioning, reduced physical pain, and perceived racial discrimination, suggesting a possible psychosocial and socio-cultural mechanism by which the intervention affects BP. In this study a CBPR guided RCT of 250 NH with physician-diagnosed HTN in Hawai'i and Washington State is offered. The effects will be compared of a 6-month intervention that combines hula training and brief culturally-tailored HTN self-management education delivered by peer educators and Kumu hula to a wait-list control group in reducing systolic BP and CVD risk scores. It will also be determined the mediating effects of health behaviors (e.g., smoking), self-regulation, and psychosocial (e.g., social support), and socio-cultural factors (e.g., perceived racism) on blood pressure reduction. The goal is to build on the existing widespread infrastructure of hālau hula and NH organizations to deliver a sustainable, culturally-preferred CVD prevention program.

Interventions

BEHAVIORALHula intervention

Hula and heart health education

Sponsors

I Ola Lahui, Inc.
CollaboratorOTHER
Ke Ola Mamo
CollaboratorOTHER
University of Washington
CollaboratorOTHER
Hui No Ke Ola Pono, Inc.
CollaboratorOTHER
Kula No Na Po'e Hawaii
CollaboratorOTHER
University of Hawaii
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Native Hawaiian ancestry * Physician diagnosed HTN * Continued SBP\>140 * Physicians approval to participate in moderate PA * No prior CVD history

Exclusion criteria

* Pregnant

Design outcomes

Primary

MeasureTime frame
Change in participants' systolic blood pressure at each time frame from baseline3 months, 6 months, and 12 months

Secondary

MeasureTime frame
Change in participants' Framingham Risk Score of 10 year CVD risk at each time frame from baseline3 months, 6 months, and 12 months

Other

MeasureTime frame
Number of Participants with improved monthly physical activity levels as assessed by the Physical Activity Questionnaire3 months, 6 months, and 12 months
Number of participants with increased scores on the Medical Outcomes Study (MOS) 36-item Social Support Survey3 months, 6 months, and 12 months
Number of participants with decreased scores on the Perceived Stress Scale3 months, 6 months, and 12 months
Number of participants with increased scores of the Exercise Self-Efficacy Scale3 months, 6 months, and 12 months
Number of participants with increased scores on the Native Hawaiian Identity Scale3 months, 6 months, and 12 months
Number of Participants with decreased scores on the Perceived Ethnic Discrimination Scale3 months, 6 months, and 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026